F. Mele

Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer

F. Porpiglia, Matteo Manfredi, F. Mele et al. · European Urology · 2016 · 199 citations · Full text

Urology, Oncology, Biopsy-naïve Patients +10

The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index—Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?

F. Porpiglia, Filippo Russo, Matteo Manfredi et al. · The Journal of Urology · 2014 · 70 citations · Full text

Multiparametric Magnetic Resonance/Ultrasound Fusion Prostate Biopsy: Number and Spatial Distribution of Cores for Better Index Tumor Detection and Characterization

F. Porpiglia, Stefano De Luca, Roberto Passera et al. · The Journal of Urology · 2017 · 60 citations

Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score

F. Porpiglia, Stefano De Luca, Roberto Passera et al. · Anticancer Research · 2016 · 49 citations · Full text

High prostate cancer gene 3 ( <scp>PCA</scp> 3) scores are associated with elevated Prostate Imaging Reporting and Data System ( <scp>PI</scp> ‐ <scp>RADS</scp> ) grade and biopsy Gleason score, at magnetic resonance imaging/ultrasonography fusion software‐based targeted prostate biopsy after a previous negative standard biopsy

Stefano De Luca, Roberto Passera, Giovanni Cattaneo et al. · British Journal of Urology · 2016 · 25 citations